Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid
US8637567B2 · kind B2 · utility
6Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 13, 2010 |
| Grant date | Jan 28, 2014 |
| Priority date | — |
| Expiry date | Oct 4, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides compounds, compositions and methods for treating a cognitive disorder or memory disorder in animals that result from aging or other neurodegenerative condition. In particular, compounds of this invention can stimulate neural cell growth, increased amounts of cells containing a key enzyme needed for production of the cholinergic neurotransmitter, and can improve memory and cognitive function in animals who have experienced a loss of memory or cognitive function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.